Nasta S - Search Results

1

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.

Frey NV, Gill S, Hexner EO, Schuster S, Nasta S, Loren A, Svoboda J, Stadtmauer E, Landsburg DJ, Mato A, Levine BL, Lacey SF, Melenhorst JJ, Veloso E, Gaymon A, Pequignot E, Shan X, Hwang WT, June CH, Porter DL. Frey NV, et al. Among authors: nasta s. J Clin Oncol. 2020 Sep 1;38(25):2862-2871. doi: 10.1200/JCO.19.03237. Epub 2020 Apr 16. J Clin Oncol. 2020. PMID: 32298202 Free PMC article. Clinical Trial.

2

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease.

Cohen AD, Luger SM, Sickles C, Mangan PA, Porter DL, Schuster SJ, Tsai DE, Nasta S, Gewirtz AM, Stadtmauer EA. Cohen AD, et al. Among authors: nasta s. Bone Marrow Transplant. 2002 Jul;30(1):23-8. doi: 10.1038/sj.bmt.1703602. Bone Marrow Transplant. 2002. PMID: 12105773

3

Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.

Gerecitano J, Mathias C, Mick R, Duffy KM, Luger S, Stadtmauer EA, Schuster SJ, Tsai D, Nasta S, Berlin J, Phillips DK, High KA, Porter DL. Gerecitano J, et al. Among authors: nasta s. J Hematother Stem Cell Res. 2003 Apr;12(2):215-23. doi: 10.1089/152581603321628359. J Hematother Stem Cell Res. 2003. PMID: 12804180

4

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.

Tsai DE, Maillard I, Schuster SJ, Nasta SD, Porter DL, Klumpp TR, Goldenberg DM, Luger SM, Alavi A, Sharkey RM, Hartzell KB, Stadtmauer EA. Tsai DE, et al. Clin Lymphoma. 2003 Jun;4(1):56-9. doi: 10.3816/clm.2003.n.015. Clin Lymphoma. 2003. PMID: 12837157

5

Use of iodine 131I-tositumomab radioimmunotherapy in a patient with Waldenstrom's macroglobulinemia.

Tsai DE, Maillard I, Downs LH, Alavi A, Nasta SD, Glatstein E, Schuster SJ. Tsai DE, et al. Leuk Lymphoma. 2004 Mar;45(3):591-5. doi: 10.1080/10428190310001597946. Leuk Lymphoma. 2004. PMID: 15160923

6

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.

Loren AW, Luger SM, Stadtmauer EA, Tsai DE, Schuster S, Nasta SD, Goldstein SC, Perl A, Orloff G, Oliver JC, Green J, Emerson SG, Porter DL. Loren AW, et al. Among authors: nasta sd. Bone Marrow Transplant. 2005 May;35(9):921-6. doi: 10.1038/sj.bmt.1704887. Bone Marrow Transplant. 2005. PMID: 15765118

7

Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.

Tsai DE, Aqui NA, Vogl DT, Bloom RD, Schuster SJ, Nasta SD, Wasik MA. Tsai DE, et al. Am J Transplant. 2005 Aug;5(8):2070-3. doi: 10.1111/j.1600-6143.2005.00948.x. Am J Transplant. 2005. PMID: 15996263 Free article.

8

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.

Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, Porter DL, Elstrom R, Tsai DE. Vogl DT, et al. Among authors: nasta sd. Leuk Lymphoma. 2005 Sep;46(9):1313-20. doi: 10.1080/10428190500158649. Leuk Lymphoma. 2005. PMID: 16109609

9

Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.

Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, Bloom RD, Brozena SC, Hodinka RL, Stadtmauer EA, Schuster SJ, Nasta SD, Porter DL, Luger SM, Klumpp TR. Tsai DE, et al. Clin Transplant. 2005 Oct;19(5):644-52. doi: 10.1111/j.1399-0012.2005.00388.x. Clin Transplant. 2005. PMID: 16146557

10

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.

Andreadis C, Schuster SJ, Chong EA, Svoboda J, Luger SM, Porter DL, Tsai DE, Nasta SD, Elstrom RL, Goldstein SC, Downs LH, Mangan PA, Cunningham KA, Hummel KA, Gimotty PA, Siegel DL, Glatstein E, Stadtmauer EA. Andreadis C, et al. Among authors: nasta sd. Bone Marrow Transplant. 2005 Dec;36(11):955-61. doi: 10.1038/sj.bmt.1705178. Bone Marrow Transplant. 2005. PMID: 16205727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page